Core Viewpoint - The arbitration ruling requires Boyuan Chemical to pay approximately 1.889 billion yuan to Wushenqi Mining Co., marking the conclusion of a long-standing dispute [1][2]. Group 1: Financial Implications - Boyuan Chemical's total expenditure related to the arbitration, including legal fees, is close to 1.91 billion yuan [1]. - The company has already accrued an estimated liability of 1.149 billion yuan in anticipation of the potential compensation [3]. - As of the end of Q3 2025, Boyuan Chemical reported a cash balance of 3.702 billion yuan [3]. Group 2: Historical Context - The dispute traces back to a 2009 agreement where Boyuan Chemical transferred a 51% stake in Mengda Mining to China Coal Energy, with the original shareholders responsible for subsequent mining rights payments [2]. - The recent ruling by the Inner Mongolia High Court on October 8, 2023, ordered Mengda Mining to pay 2.223 billion yuan, which triggered the arbitration against Boyuan Chemical [2]. Group 3: Operational Impact - Despite the financial burden, Boyuan Chemical asserts that the arbitration outcome will not significantly impact its daily operations, relying on its strong cash flow and confidence in its core business [4]. - The company is currently facing challenges in the chemical industry, with a reported revenue decline of 16.54% year-on-year for the first three quarters of 2025 [3]. - The company’s net profit for the same period decreased by 41.15%, with a more pronounced drop of 46.38% in Q3 [3]. Group 4: Future Prospects - Boyuan Chemical is pursuing growth through its Alashan natural soda project, which is expected to enhance its production capacity significantly once fully operational [4]. - The project aims to achieve an annual production capacity of 7.8 million tons of soda ash and 800,000 tons of sodium bicarbonate, potentially solidifying its market position despite current industry challenges [4].

证券代码：000683 证券简称：博源化工 公告编号：2025-091 内蒙古博源化工股份有限公司 关于部分限制性股票回购注销完成的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或者重大遗漏。 重要内容提示： 1.内蒙古博源化工股份有限公司（以下简称公司）本次回购注销的限制性股 票数量为 1,907,500 股，占回购注销前公司总股本的 0.0513%。本次回购注销完 成后，公司股份总数为 3,716,831,560 股。 2.本次回购注销涉及 20 名激励对象，首次授予限制性股票的回购价格为 3.06 元/股，预留部分的限制性股票的回购价格为 3.10 元/股。 3.截至 2025 年 12 月 9 日，上述限制性股票已在中国证券登记结算有限责任 公司深圳分公司办理完成注销手续。 一、公司 2023 年限制性股票激励计划已履行的相关审批程序 （一）2023 年 9 月 20 日，公司召开九届五次董事会和九届五次监事会，审 议通过了《关于<公司 2023 年限制性股票激励计划（草案）>及其摘要的议案》 《关于<公司 2023 年限制性股票激励计划实施考核管理办法>的 ...

Core Viewpoint - The arbitration ruling requires the company to pay a total of 1.889 billion yuan to Mengda Mining for the exploration rights price difference, stemming from a dispute with the state-owned asset management company [2][5] Group 1: Arbitration Details - The arbitration was initiated by China Coal Energy Co., Ltd. against the company and another party, Shanghai Zheda Investment Development Co., Ltd., regarding the payment responsibilities for the exploration rights [2][5] - The company has already accrued an estimated liability of approximately 1.149 billion yuan related to this arbitration matter [3] - The ruling specifies that the company and Shanghai Zheda will bear joint liability for the payment, but the internal distribution of responsibilities between them remains undetermined [6] Group 2: Historical Context - The dispute traces back to 2008 when Mengda Mining was a wholly-owned subsidiary of the company and acquired exploration rights from the state-owned asset management company [4] - In 2009, the company brought in investors, including China Coal Energy, which altered the shareholding structure of Mengda Mining [4] - The company and China Coal Energy currently hold 34% and 66% of Mengda Mining, respectively [4] Group 3: Financial Impact - The arbitration ruling is expected to have a significant impact on the company's financial status, but the exact effects cannot be accurately assessed until the accounting treatment by Mengda Mining is clarified [7] - For the first three quarters of the year, the company reported revenue of 8.656 billion yuan, a year-on-year decline of 16.54%, and a net profit of approximately 1.062 billion yuan, down 41.15% year-on-year [8]

Core Viewpoint - Inner Mongolia Boyuan Chemical Co., Ltd. has announced the trial operation of the first production line of the second phase of the Alashan Tamsu Natural Soda Development and Utilization Project, which has a capacity of 1 million tons per year of soda ash [1][2]. Group 1: Project Overview - The total planned capacity of the Alashan Tamsu Natural Soda Development and Utilization Project is 7.8 million tons per year of soda ash and 800,000 tons per year of sodium bicarbonate [1]. - The project is divided into two phases: Phase 1 has a planned capacity of 5 million tons per year of soda ash and 400,000 tons per year of sodium bicarbonate, which has already reached full production capacity; Phase 2 has a planned capacity of 2.8 million tons per year of soda ash and 400,000 tons per year of sodium bicarbonate, which began construction at the end of December 2023 [1][2]. Group 2: Future Plans and Market Position - The company plans to gradually conduct trial operations for the remaining production lines based on the overall construction progress of the second phase and the trial operation status of the first production line [2]. - The trial operation of the second phase project will further solidify the company's core business in natural soda, expand the scale of the natural soda business, and enhance market share [2].

Group 1 - Longi Green Energy has decided to terminate its plan for issuing global depositary receipts overseas and listing on the Swiss Stock Exchange, citing stable production and operations as reasons for this cautious decision [1] - Borui Communication plans to acquire a 51% stake in Meijing Technology for 66.49 million yuan to enhance its focus on modern media and digital transformation [2] - Tianyuan Dike's chairman has been placed under detention by the local supervisory authority, but the company assures that its operations remain normal and unaffected [3] Group 2 - Rhine Biotech is planning a change in control and asset acquisition, leading to a suspension of its stock trading starting December 10 [4] - Fosun Pharma's subsidiary has signed a licensing agreement with Pfizer, which includes an upfront payment of 15 million USD and potential milestone payments up to 35 million USD for the development of a GLP-1R agonist [5] - Yongmaotai intends to invest approximately 400 million yuan in a new intelligent manufacturing project for magnesium-aluminum alloy components [6] Group 3 - Huayi Group's subsidiary has been ordered to suspend operations for environmental remediation, which is expected to impact production [7][8] - Boyuan Chemical's subsidiary has commenced trial production of a 1 million tons/year soda ash production line, enhancing its market position [9] - Tiandi Technology plans to invest 3.545 billion yuan in a research center for intelligent mining equipment in Xi'an [10] Group 4 - Daye Co. has a minor stake in Jiangbei Company, which focuses on aerospace products, but its financial impact is limited due to the small shareholding [11] - Xiamen Airport is planning to acquire 100% of its controlling shareholder's subsidiary to adapt to the upcoming changes in airport operations [12] - Zhaoyi Innovation has received approval from the CSRC for its overseas listing of H-shares, planning to issue up to 51.8 million shares [13] Group 5 - Yangfan New Materials' controlling shareholder has been released from detention, allowing normal operations to resume [14] - Tangrenshen reported a decline in pig sales revenue for November, with a 24.05% decrease month-on-month [15][16] - China Merchants Shekou achieved a sales amount of 14.094 billion yuan in November, with cumulative sales reaching 170.166 billion yuan for the year [17] Group 6 - Zhengbang Technology reported a slight increase in pig sales revenue for November, with a 8.55% rise month-on-month [18] - Luoniushan's pig sales revenue increased by 13.57% year-on-year in November, despite a slight decline in monthly sales [19] - Tiankang Bio reported a 1.2% increase in pig sales revenue for November, with a year-to-date decline in total revenue [20] Group 7 - Huitai Medical plans to repurchase shares worth 200 million to 250 million yuan for employee stock ownership plans [21] - Financial Street's major shareholder increased its stake by 703,840 shares, raising its ownership to nearly 15% [22] - Shenzhou Information's major shareholder plans to reduce its stake by up to 3% [23] Group 8 - Yingpais plans to increase its stake in the company by 60 million to 120 million yuan within six months [24] - Jingu Co. intends to repurchase shares worth 30 million to 60 million yuan for employee stock ownership plans [25] - Songcheng Performing Arts plans to repurchase shares worth 100 million to 200 million yuan for capital reduction [26] Group 9 - Bai'ao Intelligent has pre-won contracts for projects totaling 27.5 million yuan, which is expected to positively impact future performance [27] - Heshun Electric has been awarded a procurement project from the State Grid worth 107 million yuan, representing nearly 25% of its projected revenue [28] - Jinggong Technology signed a sales contract worth 729 million yuan, accounting for 42.16% of its expected annual revenue [29] Group 10 - Zhongchao Holdings' subsidiary received an order for high-temperature alloy precision castings worth 51.56 million yuan [30] - Wanma Technology has pre-won multiple projects from the State Grid totaling 59.94 million yuan [31] - ST Weihai, in partnership with a construction institute, won a contract for a smart agriculture project worth 652 million yuan [32] - Chongqing Construction's subsidiary has secured a construction project worth 1.714 billion yuan [33]

Core Viewpoint - The company announced that its subsidiary, Inner Mongolia Boyuan Yingen Mining Co., Ltd., has commenced trial production of the first 1 million tons/year soda ash production line for the second phase of the Alashan Tamsu natural soda development project on December 9, 2025, which will enhance its core business and market share in the natural soda industry [1] Group 1 - The first production line of the second phase project has started trial production, with ongoing adjustments and optimizations [1] - The company plans to gradually commence trial production for the remaining production lines based on the overall construction progress of the second phase project and the trial results of the first line [1] - The trial production of the second phase project will further solidify the company's main business in natural soda and expand its business scale [1]

智通财经APP讯，博源化工(000683.SZ)公告，公司控股子公司内蒙古博源银根矿业有限责任公司(以下 简称银根矿业)在建的阿拉善塔木素天然碱开发利用项目二期第一条100万吨/年纯碱生产线，已于2025 年12月9日投料试车，目前正对装置进行调试、优化和完善。 ...

博源化工（000683）(000683.SZ)公告，公司控股子公司内蒙古博源银根矿业有限责任公司(以下简称银 根矿业)在建的阿拉善塔木素天然碱开发利用项目二期第一条100万吨/年纯碱生产线，已于2025年12月9 日投料试车，目前正对装置进行调试、优化和完善。 ...

人民财讯12月9日电，博源化工（000683）12月9日公告，公司控股子公司内蒙古博源银根矿业有限责任 公司在建的阿拉善塔木素天然碱开发利用项目二期第一条100万吨/年纯碱生产线，已于2025年12月9日 投料试车，目前正对装置进行调试、优化和完善。后续，公司将根据二期项目整体建设进度及第一条生 产线的试车情况，逐步对其余生产线进行投料试车。二期项目投料试车，将进一步夯实公司天然碱主 业，扩大天然碱业务规模，提升市场占有率。 ...

证券代码：000683 证券简称：博源化工 公告编号：2025-090 后续，公司将根据二期项目整体建设进度及第一条生产线的试车情况，逐步 对其余生产线进行投料试车。二期项目投料试车，将进一步夯实公司天然碱主业， 扩大天然碱业务规模，提升市场占有率。 银根矿业阿拉善塔木素天然碱开发利用项目二期装置试车阶段，部分设备及 工艺参数仍需进一步优化调整，从项目投料试车到全面达产达标并产生经济效益 尚需一定时间，未来可能面临政策调整、市场变化、价格波动等风险。公司将密 切关注市场动态和行业发展趋势，加强项目管理，力争尽快实现达产达标，不断 提升精细化管理水平，增强项目竞争力。 敬请广大投资者理性投资，注意投资风险。 特此公告。 1 内蒙古博源化工股份有限公司 关于控股子公司阿拉善塔木素天然碱开发利用项目 二期投料试车的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 内蒙古博源化工股份有限公司（以下简称公司）控股子公司内蒙古博源银根 矿业有限责任公司（以下简称银根矿业）在建的阿拉善塔木素天然碱开发利用项 目二期第一条 100 万吨/年纯碱生产线，已于 2025 年 ...